作者
Myriam Chalabi,Y.L. Verschoor,Pedro Batista Tan,Sara Balduzzi,Anja U. van Lent,Cecile Grootscholten,Simone Dokter,Nikè V.J.A. Büller,Brechtje A. Grotenhuis,Koert F.D. Kuhlmann,Jacobus W. Burger,Inge L. Huibregtse,Tjeerd S. Aukema,Eduard R. Hendriks,Steven J. Oosterling,Pétur Snæbjörnsson,Emile E. Voest,Lodewyk F.A. Wessels,Geerard L. Beets,Monique E. van Leerdam,Ton N. Schumacher,José G. van den Berg,Geerard L. Beets,John B.A.G. Haanen
摘要
Mismatch repair-deficient (dMMR) tumors can be found in 10 to 15% of patients with nonmetastatic colon cancer. In these patients, the efficacy of chemotherapy is limited. The use of neoadjuvant immunotherapy has shown promising results, but data from studies of this approach are limited.
JY
寻道图强
lin
Cloud
穆紫
凤凰
美好乐松
黑白
脑洞疼
结实的寄柔
可爱的函函
科目三
霉小欧
账户已注销
星辰大海
eternity136
完美的天空
mmyhn
陈军
Singularity
皖公网安备34019202002308
